Literature DB >> 5070670

Intraocular penetration of cephaloridine.

A B Richards, A J Bron, N S Rice, P Fells, M J Marshall, B R Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5070670      PMCID: PMC1208836          DOI: 10.1136/bjo.56.7.531

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Symposium on certain forms of infective kerato-uveitis or uveitis. I. An approach to the problem, and the technique of anterior chamber tap.

Authors:  B R Jones; A Patterson; N S Rice
Journal:  Trans Ophthalmol Soc U K       Date:  1969

2.  Intraocular penetration of cephalexin in man.

Authors:  G L Boyle; H F Hein; I H Leopold
Journal:  Am J Ophthalmol       Date:  1970-05       Impact factor: 5.258

3.  Intraocular penetration of cephaloridine in humans.

Authors:  F C Riley; G L Boyle; I H Leopold
Journal:  Am J Ophthalmol       Date:  1968-12       Impact factor: 5.258

4.  Ocular penetration of cephalexin in the rabbit.

Authors:  W E Gager; F J Elsas; J L Smith
Journal:  Br J Ophthalmol       Date:  1969-06       Impact factor: 4.638

5.  Regression curve analysis of cephalosporin activity.

Authors:  J A Washington; P K Yu
Journal:  Appl Microbiol       Date:  1970-04
  5 in total
  4 in total

1.  Penetration of cephaloridine into the subretinal fluid.

Authors:  A H Chignell; A J Bron; D L Easty; D A Owen
Journal:  Br J Ophthalmol       Date:  1973-06       Impact factor: 4.638

2.  Penetration of cefotaxime into the aqueous humour of the human eye after intravenous application.

Authors:  C D Quentin; R Ansorg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

3.  Ocular pharmacokinetics of tobramycin. A comparative radioimmunoassay and microbiological assay.

Authors:  S Desai
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

4.  The intraocular penetration of cefuroxime after parenteral administration.

Authors:  A B Richards; A J Bron; B McLendon; M R Kennedy; S R Walker
Journal:  Br J Ophthalmol       Date:  1979-10       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.